We conduct research related to the development of new platforms and analytical systems that are used in the construction of electrochemical (bio)sensors. Our interest are related to new biosensors, whose transducer element contains nanomaterials based on carbon or gold. As receptors (recognition element) we use biological molecules, among others: proteins, enzymes, antibodies, single-stranded nucleic acids (ssDNA), aptamers and ssDNA G-quadruplexes.
We focus on biomarkers for various diseases, such as cancer, cardiovascular disease, neurodegenerative diseases (Alzheimer`s, Parkinson`s, Hungtington`s, dementia) and diabetes. We also conduct research on the impact of selected biologically active compounds present in food on the pathologies in the the human body, such as lipoprotein oxidation and protein aggregation. Moreover, we study the inhibitory properties of new synthetic compounds against proteins, that play a key role in the human body. Additionally, we are working on systems for targeted and controlled delivery of therapeutic compounds to the cancer cells.